离子交换与吸附

[1] Vedadghavami A, Minoei F, Hosseini S S. Practical techniques for improving the performance of polymeric membranes and processes for protein separation and purification[J]. Iranian Journal of Chemistry and Chemical Engineering, 2018, 37(2):1-23.

[2] Kip C, Hamaloglu K O, Demir C, Tuncel A. Recent trends in sorbents for bioaffinity chromatography[J]. Journal of Separation Science, 2021, 44(6):1273-1291.

[3] Yamada T, Yamamoto K, Ishihara T, Ohta S. Purification of monoclonal antibodies entirely in flow-through mode[J]. Journal of Chromatography B, 2017, 1061-1062:110-116.

[4] Block H, Maertens B, Spriestersbach A, Brinker N, Kubicek J, Fabis R, Labahn J, Sch?fer F.Immobilized-metal affinity chromatography(IMAC):a review[J]. Methods in Enzymology,2009, 463:439-473.

[5] Jiang C, Liu J, Rubacha M, Shukla A A. A mechanistic study of protein A chromatography resin lifetime[J]. Journal of Chromatography A, 2009, 1216(31):5849-5855.

[6] Xia H F, Liang Z D, Wang S L, Wu P Q, Jin X H. Molecular modification of protein A to improve the elution pH and alkali resistance in affinity chromatography[J]. Applied Biochemistry and Biotechnology, 2014, 172(8):4002-4012.

[7] Blair D E, Hekmat O, Schüttelkopf A W, Shrestha B, Tokuyasu K, Withers S G, Van Aalten D M F. Structure and mechanism of chitin deacetylase from the fungal pathogen colletotrichum lindemuthianum[J]. Biochemistry, 2006, 45(31):9416-9426.

[8] Bo C, Wang C, Wei Y. Novel bis(5-methyltetrazolium)amine ligand-bonded stationary phase with reduced leakage of metal ions in immobilized metal affinity chromatography of proteins[J]. Analytical and Bioanalytical Chemistry, 2016, 408(27):7595-7605.

[9] Zhao M, Vandersluis M, Stout J, Haupts U, Sanders M, Jacquemart R. Affinity chromatography for vaccines manufacturing:finally ready for prime time[J]. Vaccine, 2019,37(36):5491-5503.

[10] Barnes B, Caws T, Thomas S, Shephard A P, Corteling R, Hole P, Bracewell D G.Investigating heparin affinity chromatography for extracellular vesicle purification and fractionation[J]. Journal of Chromatography A, 2022, 1670:462987.

[11] Yuan H, Li N, Xun Y, Wang L, Feng X, Wang Y, Tao Y, Wang S. An efficient heparin affinity column purification method coupled with ultraperformance liquid chromatography for the quantification of native lactoferrin in breast milk[J]. Journal of Food Quality, 2021,2021:4675343.

[12] Spannaus R, Miller C, Lindemann D, Bodem J. Purification of foamy viral particles[J].Virology, 2017, 506:28-33.

[13] Nasimuzzaman M, Van Der Loo J C, Malik P. Production and purification of baculovirus for gene therapy application[J]. Jove-Journal of Visualized Experiments, 2018,(134):e57019.

[14] Bergwik J, Kristiansson A, Larsson J, Ekstr?m S, kerstr?m B, Allhorn M. Binding of the human antioxidation protein α1-microglobulin(A1M)to heparin and heparan sulfate.Mapping of binding site, molecular and functional characterization, and co-localization in vivo and in vitro[J]. Redox Biology, 2021, 41:101892.

[15]赖翼,刘阳.亲和层析法制备人凝血因子Ⅸ概述[J].检验医学与临床, 2009, 6(11):893-895.

[16] Bolten S N, Rinas U, Scheper T. Heparin:role in protein purification and substitution with animal-component free material[J]. Applied Microbiology and Biotechnology, 2018, 102(20):8647-8660.

[17] Bolten S N, Knoll A S, Li Z, Gellermann P, Pepelanova I, Rinas U, Scheper T. Purification of the human fibroblast growth factor 2 using novel animal-component free materials[J].Journal of Chromatography A, 2020, 1626:461367.

[18] Gieseler G, Pepelanova I, Stuckenberg L, Villain L, Nolle V, Odenthal U, Beutel S, Rinas U, Scheper T. Purification of bone morphogenetic protein-2 from refolding mixtures using mixed-mode membrane chromatography[J]. Applied Microbiology and Biotechnology,2017, 101(1):123-130.

[19] Begi M, Peenkovic S, Gajdoik M S, Josic D, Muller E. Salt-tolerant cation exchangercontaining sulfate groups as a viable alternative for mixed-mode type and heparin-based affinity resins[J]. Biotechnology Journal, 2021, 16(11):2100100.

[20] Sugihara T, Fujiwara S, Ishioka S, Urakubo T, Suzawa T. Isolation of recombinant human antithrombin isoforms by Cellufine Sulfate affinity chromatography[J]. Journal of Chromatography B:Analytical Technologies in the Biomedical and Life Sciences, 2018,1095:198-203.

[21] Jayaraman S, Chavez O R, Perez A, Minambres I, Luis Sanchez-Quesada J, Gursky O.Binding to heparin triggers deleterious structural and biochemical changes in human lowdensity lipoprotein, which are amplified in hyperglycemia[J]. Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids, 2020, 1865(8):158712.

[22] Gandhi N S, Mancera R L. The structure of glycosaminoglycans and their interactions with proteins[J]. Chemical Biology&Drug Design, 2008, 72(6):455-482.

[23] Rodriguez E L, Poddar S, Iftekhar S, Suh K, Woolfork A G, Ovbude S, Pekarek A, Walters M, Lott S, Hage D S. Affinity chromatography:a review of trends and developments over the past 50 years[J]. Journal of Chromatography B:Analytical Technologies in the Biomedical and Life Sciences, 2020, 1157:122332.

[24] Poddar S, Sharmeen S, Hage D S. Affinity monolith chromatography:a review of general principles and recent developments[J]. Electrophoresis, 2021, 42(24):2577-2598.

[25] Seidi F, Salimi H, Shamsabadi A A, Shabanian M. Synthesis of hybrid materials using graft copolymerization on non-cellulosic polysaccharides via homogenous ATRP[J]. Progress in Polymer Science, 2018, 76:1-39.

[26]李冉.改性琼脂糖固定化酶及其应用研究[D].硕士论文,无锡:江南大学, 2021.

[27] Zhang X, Duan Y, Han N, Wu Y. Increase in lgG-binding capacity of recombinant protein a immobilized on heterofunctional amino and epoxy agarose[J]. IOP Conference SeriesMaterials Science and Engineering, 2018, 381:012042.

[28] Zhang C, Rodriguez E, Bi C, Zheng X, Suresh D, Suh K, Li Z, Elsebaei F, Hage D S. High performance affinity chromatography and related separation methods for the analysis of biological and pharmaceutical agents[J]. Analyst, 2018, 143(2):374-391.

[29]赵希鹏.硅胶的制备及应用现状[J].广州化工, 2011, 39(24):24-26.

[30] Buszewska-Forajta M, Markuszewski M J, Kaliszan R. Free silanols and ionic liquids as their suppressors in liquid chromatography[J]. Journal of Chromatography A, 2018, 1559:17-43.

[31]李恒,王少云,方嘉璇,赵岚,靳海波,何广湘,郭晓燕,谷庆阳,郝思雯,热孜亚,支伟杰,于洪斌,张荣月.大孔聚合物层析介质孔结构对蛋白载量的影响[J].高等学校化学学报, 2018, 39(12):2673-2678.

[32]张荣月,陈暄友,张祎,姜成伟,黄逸康,李强,丁虹,潘一廷,刘才.超大孔聚合物亲和色谱层析介质的制备及评价[J].分析测试学报, 2016, 35(12):1643-1646.

[33]张荣月,侯恒磊,靳海波,何广湘.一种固定化金属螯合层析介质及其制备方法与应用[P], CN111569849A, 2020-08-25.

[34]张荣月,潘一廷,冀德坤,焦玉海.一种制备高载量亲和层析介质的方法[P],CN105233807A, 2016-01-13.

[35] Xiao J, Lu Q, Cong H, Shen Y, Yu B. Microporous poly(glycidyl methacrylate-co-ethylene glycol dimethyl acrylate)microspheres:synthesis, functionalization and applications[J].Polymer Chemistry, 2021, 12(42):6050-6070.

[36] Li Z, Rodriguez E, Azaria S, Pekarek A, Hage D S. Affinity monolith chromatography:a review of general principles and applications[J]. Electrophoresis, 2017, 38(22-23):2837-2850.

[37] Pongener I, O'shea C, Wootton H, Watkinson M, Miller G J. Developments in the chemical synthesis of heparin and heparan sulfate[J]. Chemical Record, 2021, 21(11):3238-3255.

[38] Onishi A, St Ange K, Dordick J S, Linhardt R J. Heparin and anticoagulation[J]. Front Biosci(Landmark Ed), 2016, 21(7):1372-1392.

[39] Murugesan S, Xie J, Linhardt R J. Immobilization of heparin:approaches and applications[J]. Current Topics in Medicinal Chemistry, 2008, 8(2):80-100.

[40] Kavran J M, Leahy D J. Coupling antibody to cyanogen bromide-activated sepharose[J].Methods in Enzymology, 2014, 541:27-34.

[41]朱蒙,韦传宝,刘烨,罗正维.离子交换层析与亲和层析纯化猪凝血酶的比较[J].天然产物研究与开发, 2010, 22(B08):163-165.

[42] Denizli A. Heparin-immobilized poly(2-hydroxyethylmethacrylate)-based microspheres[J].Journal of Applied Polymer Science, 1999, 74(3):655-662.

[43] Zhao R, Luo J, Shangguan D, Liu G. A novel matrix for high performance affinity chromatography and its application in the purification of antithrombin III[J]. Journal of Chromatography B, 2005, 816(1-2):175-181.

[44] Zhao Y, Zhao R, Shangguan D, Xiong S, Liu G. Three novel high performance affinity chromatographic media for the separation of antithrombin III from human plasma[J].Biomedical Chromatography, 2001, 15(8):487-492.

[45]王相栋,张春妮,汪俊军,田迎.自制肝素亲和柱分离纯化载脂蛋白H及其抗体制备与鉴定[J].中国免疫学杂志, 2008, 24(10):931-934.

[46] Li M J, Li Z H, Hu J C, Dong X Z. The study of purifying plasma thrombin using chitosan affinity magnetic microspheres[J]. Progress in Biochemistry and Biophysics, 2010, 37(4):433-440.

[47]史清洪,彭冠英,孙舒,孙彦.环氧氯丙烷活化琼脂糖凝胶过程强化及性能评价[J].过程工程学报, 2007, 7(4):743-746.

[48]甄宇红,杨青,张宝.环氧氯丙烷法活化琼脂糖凝胶及其动力学分析[J].大连医科大学学报, 2005, 27(4):268-272.

[49] Jiang T, Mallik R, Hage D S. Affinity monoliths for ultrafast immunoextraction[J].Analytical Chemistry, 2005, 77(8):2362-2372.

[50] Arrua R D, Moya C, Bernardi E, Zarzur J, Strumia M, Igarzabal C I A. Preparation of macroporous monoliths based on epoxy-bearing hydrophilic terpolymers and applied for affinity separations[J]. European Polymer Journal, 2010, 46(4):663-672.

[51] Funahashi M, Matsumoto I, Seno N. Preparation of three types of heparin-sepharose and their binding activities to thrombin and antithrombin III[J]. Analytical Biochemistry, 1982,126(2):414-421.

[52] Chen L, Guo C, Guan Y, Liu H. Isolation of lactoferrin from acid whey by magnetic affinity separation[J]. Separation and Purification Technology, 2007, 56(2):168-174.

[53] Gu H, Liu Y, Yin D, Cai L, Zhang B, Zhang Q. Heparin immobilized polymeric monolithic column with submicron skeletons and well defined macropores for highly efficient purification of enterovirus 71[J]. Macromolecular Materials and Engineering, 2018, 303(12):1800411.

[54] Gu H, Liu Y, Wang L, Zhang B, Yin D, Zhang Q. Monolithic macroporous hydrogels prepared from oil-in-water high internal phase emulsions for high-efficiency purification of enterovirus 71[J]. Chemical Engineering Journal, 2020, 401:126051.

[55] Gu H, Yin D, Wang L, Zhang B, Zhang Q. Surface-initiated ARGET ATRP of poly(glycidyl methacrylate)from macroporous hydrogels via oil-in-water high internal phase emulsion templates for specific capture of enterovirus 71[J]. Colloids and Surfaces A:Physicochemical and Engineering Aspects, 2021, 615:126233.

[56] Miller-Andersson M, Borg H, Andersson L O. Purification of antithrombin III by affinity chromatography[J]. Thrombosis Research, 1974, 5(4):439-452.

[57] Nordenman B, Bj?rk I. Purification of thrombin by affinity chromatography on immobilized heparin[J]. Thrombosis Research, 1977, 11(6):799-808.

[58] Heger A, Grunert T, Schulz P, Josic D, Buchacher A. Separation of active and inactive forms of human antithrombin by heparin affinity chromatography[J]. Thrombosis Research,2002, 106(2):157-164.

[59] Zahn A, Allain J-P. Hepatitis C virus and hepatitis B virus bind to heparin:purification of largely IgG-free virions from infected plasma by heparin chromatography[J]. Journal of General Virology, 2005, 86(3):677-685.

[60] Zhu S, Liu B, Xu Y, Zhang L, Xia Z, Liu J, Zhou X, Fu Y, Allain J P, Li C. Two new purification methods of hepatitis C virus particles from serum-free culture system[J].Hepatitis Monthly, 2021, 21(6):115727.

[61] Belova L, Kochergin-Nikitsky K, Erofeeva A, Lavrov A, Smirnikhina S. Approaches to purification and concentration of rAAV vectors for gene therapy[J]. Bioessays, 2022, 44(6):2200019.

[62] Segura M M, Kamen A, Garnier A. Purification of retrovirus particles using heparin affinity chromatography[J]. Methods in Molecular Biology, 2008, 434:1-11.

[63] Segura M M, Garnier A, Durocher Y, Coelho H, Kamen A. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification[J]. Biotechnology and Bioengineering, 2007, 98(4):789-799.

[64] Du P, Sun S, Dong J, Zhi X, Chang Y, Teng Z, Guo H, Liu Z. Purification of foot-andmouth disease virus by heparin as ligand for certain strains[J]. Journal of Chromatography B:Analytical Technologies in the Biomedical and Life Sciences, 2017, 1049-1050:16-23.

[65] Park S Y, Lee J M, Kim A Y, Park S H, Kim J S, Kim H, Park J W, Park J H, Ko Y J, Park C K. Application of heparin affinity chromatography to produce a differential vaccine without eliciting antibodies against the nonstructural proteins of the serotype O foot-and-mouth disease viruses[J]. Viruses-Basel, 2020, 12(12):1405.

[66] Hu J, Ni Y, Dryman B A, Meng X, Zhang C. Purification of porcine reproductive and respiratory syndrome virus from cell culture using ultrafiltration and heparin affinity chromatography[J]. Journal of Chromatography A, 2010, 1217(21):3489-3493.

[67] Nasimuzzaman M, Lynn D, Van Der Loo J C, Malik P. Purification of baculovirus vectors using heparin affinity chromatography[J]. Molecular Therapy Methods&Clinical Development, 2016, 3:16071.

[68] Reiter K, Aguilar P P, Wetter V, Steppert P, Tover A, Jungbauer A. Separation of virus-like particles and extracellular vesicles by flow-through and heparin affinity chromatography[J]. Journal of Chromatography A, 2019, 1588:77-84.

[69] Aguilar P P, Reiter K, Wetter V, Steppert P, Maresch D, Ling W L, Satzer P, Jungbauer A.Capture and purification of human immunodeficiency virus-1 virus-like particles:convective media vs porous beads[J]. Journal of Chromatography A, 2020, 1627:461378.

[70] Mietzsch M, Broecker F, Reinhardt A, Seeberger P H, Heilbronn R. Differential adenoassociated virus serotype-specific interaction patterns with synthetic heparins and other glycans[J]. Journal of Virology, 2014, 88(5):2991-3003.